TGFB1 and neoplasm: Concurrently blocking TGF-β and CSF1/CSF1R signaling pathways significantly enhances CD8+ T cell infiltration and activation during chemotherapy, reduces the proportion of Tregs, improves the tumor immune microenvironment, and boosts the efficacy of chemotherapy.